Combining the SLP vaccine with chemo-immunotherapy in order to increase the HPV-specific T-cell ...

Prof Kees Melief speaks to ecancer at the 2019 American Association for Cancer Research (AACR) meeting about a study looking at the HPV-specific T-cell response after chemo-immunotherapy for advanced cervical cancer. Prof Melief discusses the favourability of cancer vaccines due the way then can be easily applied to large numbers of patients, their low cost and that when combined with chemotherapy and immunotherapy they can have great benefit. He reports that the focus is on virus induced cancers as the antigens are expressed in all cancer cells making them very good targets. Sign up to ecancer for free to receive tailored email alerts for more videos like this. ecancer.org/account/register.php